EOLS: Evolus, Inc.
Performance
EOLS +6.40%
Watchlist
Select an item
Summary
EOLS at a glance
EOLS returned +6.40% over the past year and -1.53% a year over five years. Its worst drop in that year was -46.54%, smaller than 28% of stocks on Redstone, and its Sharpe ratio of 0.35 beats 43% of stocks on Redstone. It pays no dividends.
Current Drawdown
-24.95%
Rolling Volatility
56.32%
Actions
Metrics
Risk Indicators
Alpha10.89%
Beta1.29x
Sharpe0.35
Sortino0.61
Omega1.07
Calmar0.14
Martin1.02
Profile
About EOLS
Evolus Inc is a performance beauty company offering medical aesthetic products in the cash-pay aesthetic market. The company's commercially available products represent two product categories within medical aesthetics: injectable neurotoxins and injectable hyaluronic acid (HA) gels.
- Sector
- Health Care
- Industry
- Pharmaceutical Preparations
- Market cap
- $461M
- Listed
- Feb 2018
- Employees
- 353
- Headquarters
- Newport Beach, CA
- Website
- evolus.com
Comparisons